Christopher E. Motter
20Patents
7h-index
80Co-inventors
68Inventor score
Filing activity: Mar 12, 2003 → Feb 16, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763731B2 | Anti-viral compounds | Human Necessities | 32 | Active |
| US8691938B2 | Anti-viral compounds | Chemistry; Metallurgy | 22 | Active |
| US8501238B2 | Anti-infective agents and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US8546405B2 | Anti-viral compounds | Chemistry; Metallurgy | 15 | Active |
| US7910595B2 | Anti-viral compounds | Chemistry; Metallurgy | 11 | Active |
| US8937150B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 9 | Active |
| US8188104B2 | Anti-infective agents and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9278922B2 | Anti-viral compounds | Human Necessities | 4 | Active |
| US9006387B2 | Anti-viral compounds | Chemistry; Metallurgy | 3 | Active |
| US7915411B2 | Anti-viral compounds | Chemistry; Metallurgy | 2 | Active |
| US9139536B2 | Anti-infective agents and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8921514B2 | Anti-viral compounds | Chemistry; Metallurgy | 1 | Active |
| US9586978B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US10039754B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8497275B2 | HCV protease inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9249138B2 | Anti-viral compounds | Chemistry; Metallurgy | 0 | Active |
| US10028937B2 | Anti-viral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US6818654B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Expired |
| US8163769B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Active |
| US8338605B2 | Anti-viral compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.